|
Synonyms: GTX-102 | GTX102
Compound class:
Nucleic acid
Comment: Apazunersen (GTX-102) is an antisense oligonucleotide (ASO) that targets the ubiquitin protein ligase E3A (UBE3A) antisense transcript, as a mechanism to restore functional UBE3A protein expression (by unsilencing the paternal allele) in neurons. It is a chimeric molecule combining locked nucleic acids (LNA) and DNA.
|
| No information available. |
Summary of Clinical Use ![]() |
| Apazunersen (GTX-102) was progressed as a clinical candidate for potential to treat Angelman syndrome [1]. In a phase 3 study apazunersen failed to meet its primary endpoint. |
| Clinical Trials | |||||
| Clinical Trial ID | Title | Type | Source | Comment | References |
| NCT06617429 | Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS) | Phase 3 Interventional | Ultragenyx Pharmaceutical Inc | The ASPIRE study | |